| Back | Table of Contents | Full Text | PDF | Similar Articles | |
Ayşegül Durmaz1, Yücel Özen2, İsmail Cihan Özbek2, Esra Adıyeke31, Seymur Kerimoğlu2, Murat Uğur2
1Department of Cardiovascular Surgery, Kocaeli University Medical Faculty, Kocaeli, Türkiye
2Department of Cardiovascular Surgery, Sancaktepe Şehit Prof. Dr. Ilhan Varank Training and Research Hospital, Istanbul, Türkiye
3Department of Anesthesia and Reanimation, Sancaktepe Şehit Prof. Dr. Ilhan Varank Training and Research Hospital, Istanbul, Türkiye
Keywords: Conscious sedation, COVID-19, ECMO, respiratory distress syndromes
Objectives: This study aimed to share our experiences using extracorporeal membrane oxygenation (ECMO) for severe coronavirus disease 2019 (COVID-19) to explain the mechanisms of disease and death related to COVID-19 and improve ECMO supportive treatment.
Patients and methods: This retrospective study was conducted with 26 COVID-19 patients (10 males, 16 females; mean age: 34.4±11.5 years; range, 12 to 59 years) who received ECMO support between January 1, 2021, and December 31, 2021. A multidisciplinary team closely followed patients with COVID-19 who required ECMO support. The data were carefully recorded, and their effects on ECMO follow-up and the results obtained were examined.
Results: Only 34.6% of the patients were able to come off ECMO support, and the mortality rate during ECMO support was 80.8%. However, the mortality rate for weaned patients decreased significantly over the last six months.
Conclusion: Overall, our findings suggest that ECMO intervention should be done early for better treatment outcomes, and mild sedation
in ECMO follow-up for COVID-19 patients is linked to lower mortality rates.
| Back | Table of Contents | Full Text | PDF | Similar Articles | |